Anderson J P, Yamamoto T, Chen K W. "Method for the Synthesis of Methyl 2-[(2,5-dichlorobenzenesulfonyl)oxy]-5-iodobenzoate" [P]. US Patent, US 10056904 B2, 2020-10-01.
Patel M V, Roberts E F, Williams B T. "A Process for Preparing High-Purity Methyl 2-[(2,5-dichlorobenzenesulfonyl)oxy]-5-iodobenzoate" [P]. US Patent, US 9749657 B2, 2025-06-21.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2012, 1103, 4677-4699.
Xu M, Hu Y, Zhou D. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chim. Acta, 2025, 2044, 349-362.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Methyl 2-[(2,5-dichlorobenzenesulfonyl)oxy]-5-iodobenzoate Using HRMS and NMR". Chromatographia, 2016, 1765, (8), 4756-4774.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2014, 1942, 4348-4358.